Author

Ka On Lam

University of Hong KongORCID 0000-0002-7523-5088Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Approach:statistical model· 1

Frequent Co-Authors

Wei DaiiD· 2 shared Alfred King-yin LamiD· 1 shared Anthony W.I. LoiD· 1 shared B. T.-t. Law· 1 shared Bryan Chee-chad Lung· 1 shared Carissa Wing-Yan WongiD· 1 shared Chi‐Leung ChiangiD· 1 shared Claudia Lai-yin Wong· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Wei DaiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer LettersPeer-reviewedMay 31, 2024

ΔNp63-restricted viral mimicry response impedes cancer cell viability and remodels tumor microenvironment in esophageal squamous cell carcinoma

Valen Zhuoyou Yu, Shan Shan So, Bryan Chee-chad Lung…·Maria Li Lung

This study identifies ΔNp63's role in restricting viral mimicry response in ESCC, reducing cell viability, and modulating tumor microenvironment immune cells.

14 citations

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsBriefings in BioinformaticsPeer-reviewedJan 16, 2024

ImmuneMirror: a Machine Learning-based Integrative Pipeline and Web Server for Neoantigen Prediction

Gulam Sarwar Chuwdhury, Yunshan Guo, Chi‐Leung Chiang…·Wei Dai

ImmuneMirror is a machine learning pipeline and web server for neoantigen prediction, showing high accuracy and identifying potential therapeutic targets in cancer.

26 citationstop 4%

humanmachine learning (classical)

𝕏 PostBluesky